Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01310075 · ClinicalTrials.gov registry record · NA
Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01310075: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT01310075 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01310075, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if the complication rate and post-surgical appearance differ based on what type of mesh is used for breast reconstruction surgery.
Interventions
- DEVICE Alloderm
- DEVICE Surgimend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-02 |
| Est. Completion | 2017-11-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01310075
The ClinicalTrials.gov registry entry for NCT01310075 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Alloderm is the first listed.
NCT01310075 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01310075 about?
NCT01310075 is a clinical study titled "Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction". The goal of this clinical research study is to learn if the complication rate and post-surgical appearance differ based on what type of mesh is used for breast reconstruction surgery.
What is the current status of trial NCT01310075?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2011-02. Estimated completion is 2017-11-08.
What interventions are being tested in trial NCT01310075?
The interventions under investigation include: Alloderm (DEVICE), Surgimend (DEVICE).
Who is sponsoring clinical trial NCT01310075?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.